Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...

Ohio Attorney General Dave Yost sent letters to 14 medical spas warning them to stop making false or misleading claims about ...

A Novo Nordisk spokesperson points to a study the company funded describing quality issues it identified with compounded versions. The company has also nominated semaglutide to be included on FDA ...

The FDA and a federal court recently made ... Ann Brown first tried semaglutide shots, the compounded version of the name brand Ozempic or Wegovy. “It seemed like I wasn’t as hungry, I didn ...

70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...

503B outsourcing facilities may continue to compound semaglutide injection products until May 22, 2025. The FDA stated the deadlines were set “to avoid unnecessary disruption to patient ...

A federal judge April 24 rejected a bid by compounding pharmacies to continue selling less expensive copies of semaglutide, Novo Nordisk's blockbuster drug sold under the brands Wegovy and Ozempic.

Noom will offer its version of compounded semaglutide — the active ingredient in Wegovy and diabetes drug Ozempic — as part of a program personalized for patients, which it says will comply ...